[ORGANIZATION]
IDH1‑mutant glioma vaccine
Featured in 1 tracked story · first seen
Situations
German glioma vaccine development
2 clusters · 7 sources · last updated
Latest: IDH1 Glioma Vaccine Shows 8-Year Survival; New Core2Edge Model Maps Tumor Infiltration
In early July 2026 German cancer researchers announced promising results from an experimental vaccine targeting aggressive brain tumors. By the end of the month, detailed findings from a phase‑1 trial of an IDH1‑mutant g